DRIVE TO SMOKE AND DOPAMINE BLOCKADE
DRIVE TO SMOKE AND DOPAMINE BLOCKADE
批准号:
2120920
负责人:
Joseph Patrick McEvoy
金额:
$13.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-07-01 至 1996-06-30
关键词:
benztropine dopamine dopamine antagonists drug administration rate /duration drug adverse effect haloperidol human subject lorazepam motivation nicotine psychomotor function psychopharmacology psychosis questionnaires schizophrenia self medication therapy compliance tobacco abuse transdermal drug delivery
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nicotine's enhancement of transmission in central dopaminergic pathways
may be a primary reinforcing mechanism which drives smoking behavior. To
explore this possibility we propose to study a group of individuals, i.e.,
patients with schizophrenia, who have a prevalence of smoking more than
twice that of the general population. Certain symptoms of this disorder
are believed due to dysfunction in dopamine pathways. Drugs to treat this
disorder block dopamine receptors.
We have developed reliable and valid measures of nicotine hunger,
including cigarette self-administration sessions in which patients have
repeated determinations of expired carbon monoxide during two hours of
free access to cigarettes, and a smoke-mixing device which permits
patients to select their preferred nicotine concentrations in cigarette
smoke. We propose to measure nicotine hunger in 72 newly admitted
patients with schizophrenia during a prospective neuroleptic-free washout,
and on three subsequent occasions during a 42 day double-blind trial
comparing three pharmacologically distinct dose levels of the dopamine
receptor blocker, haloperidol. We will examine whether, and how, nicotine
hunger changes in relation to haloperidol dose and plasma level, the
unfolding of therapeutic response, and the development of extrapyramidal
side effects.
Two weeks into the double-blind haloperidol dose comparison, we will also
determine the effects of four different dose levels of nicotine
transdermal patch (O, 7, 14, or 21 mg, administered in a Latin square
design balanced for order effects) on positive and negative
psychopathology and extrapyramidal side effects.
The proposed work will substantially clarify whether the excess of smoking
in these patients reflects their efforts to treat their disease or to
counteract the unwanted effects of its pharmacotherapy. It will also
provide important information about the relationships between nicotine and
dopamine systems which could not be obtained in other populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
7/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
-
批准号:10442520
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2021
-
负责人:Joseph Patrick McEvoy
-
依托单位:
7/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
-
批准号:10193994
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2021
-
负责人:Joseph Patrick McEvoy
-
依托单位:
7/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
-
批准号:10655396
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2021
-
负责人:Joseph Patrick McEvoy
-
依托单位:
1/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
-
批准号:8323934
-
项目类别:
-
资助金额:$32.33万
-
财政年份:2009
-
负责人:Joseph Patrick McEvoy
-
依托单位:
1/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
-
批准号:7882532
-
项目类别:
-
资助金额:$33.24万
-
财政年份:2009
-
负责人:Joseph Patrick McEvoy
-
依托单位:
1/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
-
批准号:8073566
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2009
-
负责人:Joseph Patrick McEvoy
-
依托单位:
1/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
-
批准号:7582905
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2009
-
负责人:Joseph Patrick McEvoy
-
依托单位:
Schizophenia Libility Genes among African-Americans
-
批准号:6647738
-
项目类别:
-
资助金额:$49.73万
-
财政年份:2002
-
负责人:Joseph Patrick McEvoy
-
依托单位:
Schizophenia Libility Genes among African-Americans
-
批准号:7117379
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2002
-
负责人:Joseph Patrick McEvoy
-
依托单位:
Schizophenia Libility Genes among African-Americans
-
批准号:6905606
-
项目类别:
-
资助金额:$52.01万
-
财政年份:2002
-
负责人:Joseph Patrick McEvoy
-
依托单位:
Schizophenia Libility Genes among African-Americans
-
批准号:6785857
-
项目类别:
-
资助金额:$51.31万
-
财政年份:2002
-
负责人:Joseph Patrick McEvoy
-
依托单位:
Schizophenia Libility Genes among African-Americans
-
批准号:6508194
-
项目类别:
-
资助金额:$51.3万
-
财政年份:2002
-
负责人:Joseph Patrick McEvoy
-
依托单位:
DRIVE TO SMOKE AND DOPAMINE BLOCKADE
-
批准号:2120921
-
项目类别:
-
资助金额:$13.46万
-
财政年份:1994
-
负责人:Joseph Patrick McEvoy
-
依托单位:
SMOKING, SCHIZOPHRENIA, AND ATYPICAL ANTIPSYCHOTICS
-
批准号:2410914
-
项目类别:
-
资助金额:$11.48万
-
财政年份:1994
-
负责人:Joseph Patrick McEvoy
-
依托单位:
SMOKING, SCHIZOPHRENIA, AND ATYPICAL ANTIPSYCHOTICS
-
批准号:2837860
-
项目类别:
-
资助金额:$14.49万
-
财政年份:1994
-
负责人:Joseph Patrick McEvoy
-
依托单位:
DRIVE TO SMOKE AND DOPAMINE BLOCKADE
-
批准号:2654363
-
项目类别:
-
资助金额:$3.37万
-
财政年份:1994
-
负责人:Joseph Patrick McEvoy
-
依托单位:
THE NEUROLEPTIC THRESHOLD DOSE IN ACUTE SCHIZOPHRENIA
-
批准号:3379820
-
项目类别:
-
资助金额:$21.07万
-
财政年份:1986
-
负责人:Joseph Patrick McEvoy
-
依托单位:
THE NEUROLEPTIC THRESHOLD DOSE IN ACUTE SCHIZOPHRENIA
-
批准号:3379819
-
项目类别:
-
资助金额:$15.71万
-
财政年份:1986
-
负责人:Joseph Patrick McEvoy
-
依托单位:
THE NEUROLEPTIC THRESHOLD DOSE IN ACUTE SCHIZOPHRENIA
-
批准号:3379821
-
项目类别:
-
资助金额:$15.3万
-
财政年份:1986
-
负责人:Joseph Patrick McEvoy
-
依托单位:
国内基金
海外基金
登录
查看更多内容
DRD2/ERK/β-catenin信号联合Dopamine/ERK/TH调节环介导慢性应激促进脑胶质瘤恶性进展的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:周秀萍
-
依托单位:
11C-N-CH3-Dopamine PET/MRI心脏神经显像对射血分数保留的心衰的实验研究
-
批准号:82171969
-
项目类别:面上项目
-
资助金额:56万元
-
批准年份:2021
-
负责人:王雪梅
-
依托单位:
11C-N-CH3-Dopamine心肌Micro PET/CT显像对糖尿病心脏自主神经病变的评估
-
批准号:82060323
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2020
-
负责人:何玉林
-
依托单位:
11C-N-CH3-Dopamine神经显像对心肌"缺血记忆"的实验研究
-
批准号:81460271
-
项目类别:地区科学基金项目
-
资助金额:46.0万元
-
批准年份:2014
-
负责人:王雪梅
-
依托单位:
11C-dopamine PET/CT显像对急性心肌缺血状况下交感神经功能变化的实验研究
-
批准号:81060019
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:王雪梅
-
依托单位: